PegIntron Redipen vs Pegasys

PegIntron Redipen
(Rx)
Pegasys
(Rx)
PegIntron Redipen is an antiviral drug.
Pegasys is an antiviral drug.
Satisfaction Score
?
No score available
Satisfaction Score
?
3.1
Moderately Satisfied
Helpfulness
for Hep C
2.6
Concern level
1.8
Approval Date
+ -
January 19, 2001
October 16, 2002
Number of discussions around the web Number of discussions + -
68 Discussions
16,766 Discussions
Taken For
+ -
Condition
Number of posts
#1 for Fibrosis
#2 for Hep C
#3 for Infection
PegIntron Redipen is prescribed for Fibrosis, Hep C and Infection and is mostly mentioned together with these indications.
Condition
Number of posts
#1 for Hep C
#2 for Cirrhosis
#3 for Infection
#4 for Fibrosis
#5 for Liver Damage
#7 for Hep B
Pegasys is prescribed for Hep C, Cirrhosis, Fibrosis and Infection and is mostly mentioned together with these indications.
Side Effects and Concerns
+ -
Peg
Sweating
10
Chills
10
Burning
10
Bruise
3
Headaches
3
Flu
3
Bone Pain
3
Insomnia
3
Anemia
1
Rash
1
Peg
Anemia
3
Headaches
2
Rash
2
Nausea
2
Fever
1
Hair Loss
1
Anxiety
1
Insomnia
1
Flu Like Symptoms
1
Weakness
1
Compare concerns
By:
PegIntron Redipen
Peg
Pegasys
Peg
Sweating
Peg
Peg
10
0
Chills
Peg
Peg
10
0
Burning
Peg
Peg
10
0
Bruise
Peg
Peg
3
0
Headaches
Peg
Peg
3
2
Flu
Peg
Peg
3
0
Bone Pain
Peg
Peg
3
0
Insomnia
Peg
Peg
3
1
Anemia
Peg
Peg
1
3
Rash
Peg
Peg
1
2
Anemia
Peg
Peg
3
1
Headaches
Peg
Peg
2
3
Rash
Peg
Peg
2
1
Nausea
Peg
Peg
2
0
Fever
Peg
Peg
1
0
Hair Loss
Peg
Peg
1
0
Anxiety
Peg
Peg
1
0
Insomnia
Peg
Peg
1
3
Flu Like Symptoms
Peg
Peg
1
0
Weakness
Peg
Peg
1
0
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
C Category C
Before taking PegIntron Redipen during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
C Category C
Before taking Pegasys during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Alcohol warning
+ -
There may be a negative interaction between PegIntron Redipen and alcohol.
There may be a negative interaction between Pegasys and alcohol.
Method of use
+ -
Injection
Injection
Dosages
+ -
Injector: 50 mcg/0.5 mL, 80 mcg/0.5 mL, 120 mcg/0.5 mL, 150 mcg/0.5 mL
Solution: 180 mcg/mL
Syringe: 180 mcg/0.5 mL
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Peginterferon Alfa-2b
Peginterferon Alfa-2a
Drug Interactions
+ -
Interaction between PegIntron Redipen and Pegasys: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
PegIntron Redipen
Read more about:
Pegasys
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 16 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...